
Lonza Receives Swissmedic Approval for Highly Potent Biologics Drug Product Filling Line in Stein (CH)
New aseptic state-of-the-art filling line in Stein (CH) designed for biologics and highly potent

New aseptic state-of-the-art filling line in Stein (CH) designed for biologics and highly potent
Ethris, a clinical-stage biotechnology company pioneering next-generation RNA therapeutics and vaccines, and Lonza, one of the world’s largest contract development and manufacturing organizations (CDMOs), have announced a collaboration to..